| May act as a tumor suppressor gene in ocular adnexal marginal zone B cell lymphoma; loss of this gene may play an important role in lymphomagenesis. | lymphoma, |
| TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. | lymphoma, |
| TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. | lymphoma, |
| Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in chronic lymphocytic leukemia | leukemia, |
| miR-29 has a role in protecting the tumor suppressor A20 mRNA from degradation by HuR in sarcoma | sarcoma, |
| Our study confirms the involvement of the TNFAIP3 tumor suppressor gene in classic Hodgkin lymphoma. | lymphoma, |
| The data demonstrate that miR-125b regulates nasopharyngeal carcinoma cell proliferation and apoptosis by targeting A20/NF-kappaB signaling pathway, and miR-125b acts as oncogene, whereas A20 functions as tumor suppressor. | nasopharyngeal,laryngeal, |
| Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling. | None |
| B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice. | None |
| Tumor suppressor TNFAIP3 (A20) is frequently deleted in S?Ūzary syndrome. | None |